MSC-PET • RESEARCH USE ONLY

Pet Mesenchymal Stem Cells

Multipotent mesenchymal stem cells derived from allogeneic umbilical cord tissue and cultured for veterinary use in companion animals such as dogs and cats. They support regeneration, inflammation modulation, and immune regulation.

Companion allogeneic UCT
VETERINARY MSC PLATFORM
Cord-tissue MSCs cultured for dogs and cats — multipotent toward bone, cartilage, muscle, and fat with systemic or local delivery options.
Younger vs marrow / fat
SOURCE BIOLOGY
Contrasted with adipose or bone marrow MSCs: higher proliferation and paracrine output, lower immunogenicity, and cross-breed allogeneic use without rejection in typical veterinary presentations.
Inflammation · degeneration
CLINICAL POSITIONING
Used in models of chronic inflammation, tissue degeneration, immune dysregulation, orthopedic disease, IBD/atopy, organ compromise, and post-surgical recovery.
ROUTES, FORMATS & APPLICATIONS
Routes
IVIAIMIT
Quantities
10 Million2ml
25 Million5ml
Potential Applications
  • Orthopedic conditions (osteoarthritis, dysplasia, ligament tears)
  • Atopic dermatitis; inflammatory bowel disease
  • Liver disease; kidney insufficiency; cardiomyopathies
  • Surgical recovery
  • Pain management (chronic inflammation, reduced NSAID reliance)
  • Anti-aging & wellness (aging pets)

Compliance · Animal Stem Cells

cGMP manufacturing & cryopreservation

Cells are manufactured under cGMP conditions and cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

cGMPNON-TOXIC CRYOPRESERVATION>98% VIABILITY
Viability & cryopreservation

Cryopreserved using a non-toxic, glucose-based method with greater than 98% viability.

GLUCOSE-BASED CRYO>98% VIABILITY

Explore More

Keep browsing our product lineup